Arlo N. McGinn, Ph.D.
Affiliations: | 2013 | Pharmacology and Toxicology | University of Utah, Salt Lake City, UT |
Area:
Pharmacy, Pharmacology, GeneticsGoogle:
"Arlo McGinn"Mean distance: 17.61 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| William R. Crowley | grad student | 2013 | University of Utah | |
| (Bioreducible polymer-mediated gene therapy for the treatment of ischemic heart disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lee Y, McGinn AN, Olsen CD, et al. (2013) Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 24-32 |
| Won YW, McGinn AN, Lee M, et al. (2013) Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia. Biomaterials. 34: 6229-38 |
| Won YW, McGinn AN, Lee M, et al. (2013) Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier. Molecular Pharmaceutics. 10: 378-85 |
| McGinn AN, Nam HY, Ou M, et al. (2011) Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials. 32: 942-9 |
| Nam HY, McGinn A, Kim PH, et al. (2010) Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials. 31: 8081-7 |